Please select an option below to help us tailor your newsletter to best suit your content interests!
Nancy Childress is a metastatic breast cancer survivor, treated here at West Cancer Center. During the month of June, we asked our West family to share their stories of survivorship to help raise awareness for this disease and to encourage others currently fighting. Nancy was kind enough to share her story with us, written… Read more »
Results from a partnership to address disparities and enhance the quality of breast cancer care at Memphis-based West Cancer Center & Research Institute were announced today. The program is sponsored by Amgen. “Our goal is to reduce breast cancer-related mortality disparity rates of Black women in the Memphis area, where the current disparity rate is approximately 70 percent –… Read more »
Our Medical Oncology & Hematology specialists work together with a highly collaborative, multidisciplinary team evaluating new research options and individual treatment plans. At West Cancer Center & Research Institute we offer the most comprehensive approach to cancer care. Our medical oncologists work closely with oncology surgeons, radiation oncologists, clinical researchers, radiologists, pathologists, genetic counselors, psychologists... Read more »
The 6th Annual West Oncology Conference will serve as a valuable forum for the presentation and discussion of new research findings. Participants will be provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer care, gastrointestinal cancers, hematological malignancies, and lung cancer in a practical and interactive format, fostering discussion… Read more »
Lee S. Schwartzberg, MD, of the West Cancer Center, discusses phase III results from the CONTESSA study, which showed that an all-oral regimen of tesetaxel plus a reduced dose of capecitabine significantly improved progression-free survival compared with capecitabine alone in patients with HER2-negative, hormone receptor–positive metastatic breast cancer previously treated with a taxane (Abstract GS4-01)…. Read more »
Gregory Vidal, MD, PhD, West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in HER2-positive breast cancer. Gregory Vidal, MD, PhD, of West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in… Read more »
OneR and West Cancer Physicians Give Ten Presentations at SABCS  OneOncology, the national network of independent oncology practices, announced today that physicians from OneR, the OneOncology Research Network and West Cancer and Research Institute will share results from ten research studies at the San Antonio Breast Cancer Symposium® (SABCS®), an international gathering of physicians and… Read more »